Gujarat Magazine

Top Realtor Andy Yau Lists Premier Investment Property in Milton, NH

 Breaking News
  • No posts were found

Top Realtor Andy Yau Lists Premier Investment Property in Milton, NH

May 15
19:46 2024

Milton, NH – May 15, 2024 – Andy Yau, recognized as one of the top ten realtors by Fastexpert in New Hampshire, proudly announces a prime investment opportunity: a fully updated quadplex located at 62 Charles St, Milton. This property is ideal for investors seeking a high return, offering a cap rate of over 10% with additional value through condo conversions.

“Investors will find everything they’re looking for in this property,” states Andy Yau. “It’s been renovated to the highest standards, ensuring it appeals to the most selective buyers.”

The quadplex has undergone extensive renovations, featuring brand-new kitchens with granite countertops, custom cabinets, recessed lighting, and modern stainless steel appliances. Each unit is designed with a meticulous eye for detail, ensuring long-term tenant satisfaction and maximum rental income.

In the current real estate climate, this offering is particularly attractive. The average price of a single-family home in New Hampshire has now surpassed $500,000, reflecting a 13.7% increase over the past year due to ongoing inventory shortages. “With the real estate market being as competitive as it is, investment properties are in high demand,” explains Yau. “There are only about 300 active multi family listings across New Hampshire, highlighting the scarcity and desirability of properties like this quadplex.”

Prospective buyers are encouraged to act swiftly. “This property is a rare find and won’t stay on the market for long,” says Yau. “Its exceptional renovations and high return on investment make it a standout opportunity.”

For more information or to arrange a viewing, please contact Andy Yau at 603-969-621 or visit

Media Contact
Company Name: Andy Yau- RE/MAX Shoreline
Contact Person: Andy Yau
Email: Send Email
Phone: 603-969-6216
Country: United Kingdom

Recent Posts

Diabetic Foot Ulcers Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Medline, B. Braun, Organogenesis, 3M, Smith & Nephew

Read Full Article